| 27 Dec 2006 |
Merck & Co., Inc. and Crucell Sign Cross-licensing Agreement on Vaccine Production Technology |
| 22 Dec 2006 |
Rhein Biotech shareholders approve merger with Crucell subsidiary |
| 22 Dec 2006 |
Crucell subsidiary awarded EU grant to develop malaria vaccine |
| 19 Dec 2006 |
Crucell and NIH Gain Approval and Move to Recruitment for Malaria Vaccine Clinical Study |
| 15 Dec 2006 |
Crucell Reports First Orders For Contract Manufacturing Agreement with Wyeth Biotech |
| 13 Dec 2006 |
Crucell Announces Start of Rabies Antibody Product Clinical Trial |
| 08 Dec 2006 |
Crucell Awarded an additional Quinvaxem(TM) Vaccine contract of over $20 Million for 2007 |
| 01 Dec 2006 |
Crucell Awarded Contracts of Over $230 Million for Quinvaxem(TM) and Hepavax-Gene® Vaccines |
| 23 Nov 2006 |
Crucell Announces Completion of Acquisition of SBL Vaccin AB |
| 21 Nov 2006 |
Crucell Announces Acquisition of SBL Vaccin AB and Offering of New Ordinary Shares |
| 16 Nov 2006 |
Rhein Biotech N.V. to be delisted from Frankfurt stock exchange |
| 16 Nov 2006 |
Crucell Presents Update on Products and Programs at New York Analyst Meeting |
| 14 Nov 2006 |
Crucell Announces Third Quarter 2006 Results |
| 09 Nov 2006 |
Crucell to Webcast Analyst Meeting on November 16, 2006 |
| 08 Nov 2006 |
DSM and Crucell Celebrate Opening of PERCIVIA PER.C6® Development Center in Cambridge, Mass. |
| 03 Nov 2006 |
The Netherlands Invest €18.4 Million to Develop Better Vaccines to Fight Raging TB Pandemic |
| 31 Oct 2006 |
Crucell to Release Q3 2006 Results on Tuesday, November 14, 2006 |
| 30 Oct 2006 |
Crucell to Concentrate Research and Development in Leiden, The Netherlands |
| 25 Oct 2006 |
Crucell and AERAS Announce Start of Tuberculosis Vaccine Clinical Trial |
| 18 Oct 2006 |
Crucell Announces Analyst Meeting on November 16, 2006 |
| 18 Oct 2006 |
Crucell to Present at Sanders Morris Harris Middle Market Investor Growth Conference, New York, October 23 |
| 11 Oct 2006 |
Crucell Announces PER.C6® Commercial Licensing Agreement with ADImmune Corporation |
| 09 Oct 2006 |
Crucell Secures $16.2 million NIH Contract for HIV Vaccine Design and Development |
| 05 Oct 2006 |
Crucell Announces Placement of First Module of New GMP Process Technology Center |
| 02 Oct 2006 |
Crucell Announces Acquisition of Berna Products Corp. from Acambis |
| 26 Sep 2006 |
Crucell Announces WHO Prequalification for Quinvaxem(TM) Vaccine |
| 26 Sep 2006 |
Sanofi Pasteur PER.C6®-based Seasonal Influenza Vaccine Enters First Clinical Trial |
| 26 Sep 2006 |
Crucell and NIH VRC Announce Start of Ebola Vaccine Clinical Trial |
| 20 Sep 2006 |
Crucell to Present at UBS Global Life Sciences Conference, New York, September 28 |
| 19 Sep 2006 |
Sanofi Pasteur Broadens Pandemic Preparedness With First Clinical Trial Of Novel PER.C6®-based H7N1 Vaccine |
| 14 Sep 2006 |
Crucell Announces STAR(TM) Technology Research License Agreement |
| 08 Sep 2006 |
Crucell Confirms Delisting of Berna Biotech |
| 07 Sep 2006 |
Crucell and UCB sign STAR(TM) License Agreement |
| 29 Aug 2006 |
Berna Biotech Ltd (SWX: BBIN) announces half-year results 2006 |
| 29 Aug 2006 |
Crucell Announces Second Quarter 2006 Results |
| 17 Aug 2006 |
Crucell and DSM Biologics Announce Second PER.C6® Licensing Agreement with MorphoSys |
| 15 Aug 2006 |
Crucell to Release Q2 2006 Earnings on Tuesday, August 29, 2006 |
| 18 Jul 2006 |
Crucell Announces Suspension of Aerugen® Clinical Development |
| 10 Jul 2006 |
Crucell and DSM Biologics Announce Invitrogen as First Partner in PER.C6® Vendor Network |
| 28 Jun 2006 |
DSM and Crucell Announce New CEO and Establishment of PER.C6® R&D Center in Boston Area |
| 20 Jun 2006 |
Crucell Announces PER.C6® Licensing Agreement with Immuno-Biological Laboratories |
| 15 Jun 2006 |
Second Tokyo Infectious Diseases Forum Highlights Crucial Vaccine Initiatives to Fight the 'Big Three' |
| 08 Jun 2006 |
Crucell to Present at Goldman Sachs Global Healthcare Conference, June 13, and Needham & Company Biotechnology and Medical Technology Conference, June 15 |
| 02 Jun 2006 |
Crucell Supervisory Board Chairman Mr Pieter Strijkert to Step Down; Succeeded by Mr Jan Oosterveld |
| 31 May 2006 |
Crucell Announces Large Human Clinical Trial with Avian Influenza Vaccine |
| 23 May 2006 |
Crucell Announces First Quarter 2006 Results |
| 22 May 2006 |
Crucell Announces PER.C6® and ceNOS Licensing Agreements with BIOA&D |
| 16 May 2006 |
Crucell Announces PER.C6® Licensing Agreement with Upstate USA |
| 15 May 2006 |
Crucell Annual General Meeting of Shareholders to be Held in Leiden on June 2, 2006 |
| 09 May 2006 |
Crucell to Release Q1 2006 Earnings on Tuesday, May 23 |
| 09 May 2006 |
Crucell Ends PER.C6® Patent Infringement Case as Final Demands are Satisfied |
| 28 Apr 2006 |
Crucell 2005 Annual Report Available Online |
| 27 Apr 2006 |
Crucell Presents Update on Strategy and Operations at Analyst Briefing |
| 26 Apr 2006 |
Crucell Analyst Briefing Update |
| 13 Apr 2006 |
Crucell to Webcast Analyst Day on April 27, 2006 |
| 12 Apr 2006 |
Crucell Files for Cancellation of Remaining Berna Biotech Minority Shares |
| 06 Apr 2006 |
Crucell announces STAR(TM) Research License Agreement |
| 05 Apr 2006 |
Crucell to divest Gräub AG, the veterinary business of Berna Biotech |
| 29 Mar 2006 |
Crucell Adopts IFRS as Primary Reporting Method and Announces 2006 Financial Calendar |
| 27 Mar 2006 |
Crucell to sell Rhein Biotech GmbH to Dynavax |
| 27 Mar 2006 |
Crucell Announces Product Approval in Korea for Quinvaxem(TM) Vaccine |
| 14 Mar 2006 |
Crucell and DSM Biologics Announce PER.C6® Licensing Agreement with UCB |
| 09 Mar 2006 |
Crucell and DSM Biologics Announce PER.C6® Licensing Agreement with UMN Pharma |
| 22 Feb 2006 |
First Trading Day of Crucell Shares on SWX Swiss Exchange |
| 24 Jan 2006 |
Crucell Announces 2005 Annual Results |
| 18 Jan 2006 |
Crucell and Ark Therapeutics Extend PER.C6® Agreement with Commercial License |
| 13 Jan 2006 |
Crucell to Release 2005 Earnings on Tuesday, January 24, 2006 |
| 11 Jan 2006 |
Berna Shareholders Open Door for Combination with Crucell |
| 10 Jan 2006 |
Crucell Shareholders Approve Exchange Offer for Berna Biotech |
| 10 Jan 2006 |
Crucell Issues Trading Update |
| 05 Jan 2006 |
Crucell Licenses STAR(TM) Technology to XOMA for Research Use |
